Senior Principal, Brand and Commercial Strategy / Financial Institutions Consulting, IQVIA
Vice President, Thought Leadership & Innovation, IQVIA U.S.
Founding Chief Executive Officer, Newleos Therapeutics Executive Partner, Longwood Fund
This session examines how emerging biopharma leaders and investors can navigate a rapidly shifting funding environment shaped by scientific innovation, economic uncertainty, pricing scrutiny, and evolving policy pressures. It highlights how strategic agility, differentiated science, and strong partnerships can support sustainable growth and smarter capital allocation in a risk sensitive market.
A strong understanding of these dynamics can help leaders make informed decisions and position their organizations for long term success. Register now to gain insights that can guide your next phase of growth.
Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.
